You are now leaving XTANDI.com
The website you are about to visit is not owned or controlled by Astellas. Astellas are not responsible for the information or services on this site.
NORTHBROOK, Ill., Oct. 30, 2013 /PRNewswire/ -- Astellas US LLC ("Astellas"), a subsidiary of Astellas Pharma Inc. based in Tokyo, Japan, welcomes Jeffrey Winton as senior vice president, chief communications officer. Winton will report to Masao Yoshida, CEO, Astellas. In this newly created position, Winton will have responsibility for corporate brand and reputation management in the Americas.
(Photo: http://photos.prnewswire.com/prnh/20131030/CG07002)
"I am pleased to add Jeff to our senior management team at Astellas," said Yoshida. "Jeff brings with him the broad industry expertise and experience we are looking for to help propel the Astellas brand in the Americas."
Winton has more than 30 years of communications experience in the pharmaceutical industry and has successfully led large, global teams. Most recently, Winton was the Vice President/Head, Global Communications and member of Global Corporate Affairs Leadership Team at Eli Lilly and Company. In this role, his responsibilities included CEO/executive communications, corporate/financial communications, government and policy communications, business communications and employee engagement. Prior to his tenure at Eli Lilly, Winton held senior communications roles at major global pharmaceutical companies such as Schering-Plough and Pharmacia. Winton holds a Bachelor of Science degree in life sciences from Cornell University in Ithaca, New York.
About Astellas
Astellas US LLC, located in Northbrook, Illinois, is an affiliate of Tokyo-based Astellas Pharma Inc. Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. For more information on Astellas, please visit our website at www.astellas.us.
SOURCE Astellas US, LLC
Get only the email alerts you want.
For media inquiries and reporter requests, please email us at corporate.communications@us.astellas.com.
Our communications team will respond to verified media requests within 24-48 hours as appropriate.
If you are not a reporter and need assistance, please visit our contact us page that includes information for patients, healthcare providers and researchers.
This website is intended for U.S. residents only. This website contains information about products that may not be available in all countries, or may be available under different trademarks, for different indications, or in different dosages. Nothing contained herein should be considered a solicitation, promotion or advertisement for any drug including those under development. Any information on the products contained herein is not intended to provide medical advice nor should be used as a substitute for the advice provided by your physician or other healthcare provider.
The site uses cookies to provide you with a more responsive and personalized service and to analyze site traffic. By using this site, you accept our use of cookies as described in our privacy policy. Please read our privacy policy for more information on the cookies we use, the processing of your personal data and how to delete or block the use of cookies.